Sentire(R) Surgical System Receives EU CE Mark (MDR) and Singapore HSA Approval, Cornerstone Robotics Accelerates Global Strategic Expansion
Unitree Robotics IPO Review Approaches, Shoucheng Holdings Robot Assets Poised for Valuation Re-rating
Patents Build Solid Barriers, Technologies Achieve All-Round Breakthroughs, New Vision Leads the New Track of AR Interaction
How to Manage Large Purchases During Sale Season Responsibly
Sentire(R) Surgical System Receives CE Mark (MDR) and Singapore HSA Dual Certification, Cornerstone Robotics Enters a New Era in its Global Expansion
WARREN, N.J., Feb. 28, 2022 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical…
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) — In a release issued under…
IRVINE, Calif.–(BUSINESS WIRE)–Allen Matkins, a California-based, full-service real estate and business law firm, announced today…
Deal deepens iCapital’s relationship with one of the fastest growing Asian private banks and accelerates…
CHICAGO, Feb. 28, 2022 (GLOBE NEWSWIRE) — Cosmos Holdings, Inc. (“the Company”) (Nasdaq: COSM), an…
CAMBRIDGE, Mass., Feb. 28, 2022 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology…
OTO-313 Phase 2 trial in tinnitus fully enrolled ahead of schedule with top-line results expected…
Cash and cash equivalents totaled €258.8 million as of December 31, 2021, which includes the…
— First Participants Dosed in Phase 1/2 Clinical Study Evaluating VAX-24 for the Prevention of…
RAS(ON) Inhibitor Pipeline Continues to Advance and Expand, Now Addressing Majority of RAS-Addicted Cancers; Two…
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX),…
Global biopharmaceutical industry senior executive with over 15 years of operational leadership with transactional and…
Provides 10-year market exclusivity in EU upon regulatory approval DEVON, Pa., Feb. 28, 2022 (GLOBE…
CAMBRIDGE, Mass., Feb. 28, 2022 (GLOBE NEWSWIRE) — Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a company…
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals (Nasdaq: DAWN),…
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) — Imago BioSciences, Inc. (“Imago”) (Nasdaq:…
Demonstrated tangible market progress and shipped 17 instruments through year end 2021 REDWOOD CITY, Calif.,…
Preliminary full year 2021 total revenues were $579.8 million; an 11% increase compared to $520.4…
EMERYVILLE, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) — Berkeley Lights, Inc. (Nasdaq: BLI), a leader…
Developing bemnifosbuvir (AT-527), a nucleotide analog, as preferred backbone of combination therapy for COVID-19, progressing…